ETFs Are Net Sellers of Kenvue (KVUE) on Oct. 30

This article first appeared on GuruFocus .

ETF flows out of Kenvue ( KVUE ) turned negative for a second straight session, with a net $530.3 million sold in Friday's session. That followed a net $1.2 million sold on Thursday, after net buying of $22.1 million on Wednesday and $0.7 million on Tuesday. More ETFs traded the other way, with 24 funds buying versus 18 selling, but the sellers moved larger amounts. Another 98 ETFs held their positions.

• Warning! GuruFocus has detected 4 Warning Sign with KVUE.

• Is KVUE fairly valued? Test your thesis with our free DCF calculator.

For the full record of ETF and guru buying and selling in KVUE, see the KVUE guru trades page .

Which ETFs sold KVUE on Friday?

The largest sellers by dollar value were NOBL ($165.5 million), SDY ($47.6 million) and FLQM ($15.3 million). In all, 24 ETFs added shares and 18 cut them.

NOBL accounted for the largest share of the move, cutting its position by 8,568,967 shares for a $165.5 million reduction and exiting its stake entirely. SDY reduced its holding by 2,467,400 shares, a $47.6 million change that left it with 16,221,380 shares, or 1.41% of the portfolio, down 13.2%. FLQM shed 792,774 shares for $15.3 million, while SPYI , BBUS , SSO , FLSP and UPRO each trimmed smaller stakes. Kenvue sits in the Consumer Defensive sector and the Household & Personal Products industry, with a market cap of $37.1 billion.

Have ETFs been buying or selling KVUE lately?

Over the last 5 reported days, ETFs were net buyers on 2 and net sellers on 3, so the recent trend is mostly selling.

What does KVUE do?

Kenvue Inc. is a pure-play consumer health company based in the United States, spun off from Johnson & Johnson and taken public in 2023. It develops, markets, and sells over-the-counter medicines, personal care, and skin health products through three segments: Self Care, Skin Health and Beauty, and Essential Health.

Kenvue reported trailing-12-month revenue of $15.53 billion, up 3.7% over the past year, with a gross margin of 58.6% and a net margin of 10.9%. Its P/E is 21.97, P/B 3.65 and P/S 2.39, against a market cap of $37.1 billion. The GF Score is 76, and GF Value of $19.62 compares with a price of $19.31. The dividend yield is 4.58%, and the stock is up 17.25% year to date.